Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA6 | P23280 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | NQO2 | P16083 | 2/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.40 |
| ▸ | TUBB | P07437 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27806279 | 0.86 | CA2 (0.50) | ACHECA2CA4ALDH1A1TSHR | |
| SCHEMBL14438192 | 0.84 | ACHE (0.43) | ACHECA2CA4ALDH1A1TSHR | |
| SCHEMBL27984936 | 0.81 | ALOX5 (0.47) | ACHECA2CA4CYP3A4MAPT | |
| SCHEMBL28870388 | 0.79 | CA2 (0.67) | ACHECA2CA4ALDH1A1TSHR | |
| SCHEMBL4209565 | 0.79 | ACHE (0.41) | ACHECA2CA4ALDH1A1TSHR | |
| SCHEMBL30835564 | 0.78 | ACHE (0.56) | ACHEALDH1A1CYP3A4MAPTCA9 | |
| SCHEMBL1243920 | 0.78 | ACHE (0.56) | ACHEALDH1A1CYP3A4MAPTCA9 | |
| SCHEMBL5142104 | 0.77 | ACHE (0.44) | ACHECA2CA4ALDH1A1TSHR | |
| SCHEMBL6888521 | 0.77 | CA2 (0.41) | ACHECA2CA4ALDH1A1PTPN1 | |
| SCHEMBL13063307 | 0.77 | CYP19A1 (0.42) | ACHECA2CA4ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60019740-A | — | — | None | — | — | JP | disclosed |
| JP-60019741-A | — | — | None | — | — | JP | disclosed |
| US-12545695-B2 | Compounds for inhibiting neovascularization factors and use thereof | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2026-02-10 | — | — | US | disclosed |
| US-20240300987-A1 | TRAP1 INHIBITOR AND USE THEREOF | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2024-09-12 | — | — | US | disclosed |
| CN-114901290-B | Compounds for inhibiting angiogenesis factors and uses thereof | 蔚山科学技术院 | 2024-09-03 | — | — | CN | disclosed |
| EP-4357351-A1 | TRAP1 INHIBITOR AND USE THEREOF | Smartin Bio Inc. (KR) | 2024-04-24 | — | — | EP | disclosed |
| CN-117769559-A | TRAP1 inhibitors and uses thereof | 斯玛特恩生物公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-4249473-A1 | DEUTERATED 1,4-BENZODIAZEPINE-2,5-DIONE COMPOUND AND USE THEREOF | Ningbo Combireg Pharmaceutical Technology Co., Ltd (CN) | 2023-09-27 | — | — | EP | disclosed |
| US-20230088747-A1 | COMPOUNDS FOR INHIBITING NEOVASCULARIZATION FACTORS AND USE THEREOF | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2023-03-23 | — | — | US | disclosed |
| WO-2022265178-A1 | TRAP1 INHIBITOR AND USE THEREOF | 주식회사 스마틴바이오 | 2022-12-22 | — | — | WO | disclosed |
| US-20070185064-A1 | 2-Aminopurine Analogs Having HSP90-Inhibiting Activity | CONFORMA THERAPEUTICS CORPORATION (US) | 2007-08-09 | — | — | US | disclosed |
| US-20070185064-A1 | 2-Aminopurine Analogs Having HSP90-Inhibiting Activity | CONFORMA THERAPEUTICS CORPORATION (US) | 2007-08-09 | — | — | US | disclosed |
| US-20060194849-A1 | Fungicidal composition and method for controlling plant diseases | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2006-08-31 | — | — | US | disclosed |
| EP-1679003-A1 | BACTERICIDE COMPOSITION AND METHOD OF CONTROLLING PLANT DISEASE | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| US-6767923-B2 | Benzhydryl derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-27 | — | — | US | disclosed |
| EP-1308433-B1 | Benzhydryl derivatives | BASF AG (DE) | 2004-04-28 | — | — | EP | disclosed |
| US-20030207938-A1 | Such as 5-bromo-6,6'-dimethyl-2,2',3',4'-tetramethoxybenz-hydryl alcohol for controlling harmful phytopathogenic fungi | BASF AKTIENGESELLSCHAFT (DE) | 2003-11-06 | — | — | US | disclosed |
| EP-1308433-A1 | Benzhydryl derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-07 | — | — | EP | disclosed |
| JP-S6019740-A | PRODUCTION OF 2,3,4,5-TETRAMETHOXYTOLUENE | SAN EI CHEM IND LTD | 1985-01-31 | — | — | JP | disclosed |
| JP-S6019741-A | PRODUCTION OF 2,3,4,5-TETRAMETHOXYTOLUENE | SAN EI CHEM IND LTD | 1985-01-31 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207938-A1 | Such as 5-bromo-6,6'-dimethyl-2,2',3',4'-tetramethoxybenz-hydryl alcohol for controlling harmful phytopathogenic fungi | CBR1, CBR3, ADH5 | ACHE 4795/4885CA2 2414/4885CA4 1805/4885 |
| US-12545695-B2 | Compounds for inhibiting neovascularization factors and use thereof | VEGFA, FLT1, KDR | ACHE 4486/4885CA2 427/4885CA4 196/4885 |
| US-20240300987-A1 | TRAP1 INHIBITOR AND USE THEREOF | TRAP1, PPP1R7, PPP1R15A | ACHE 4833/4885CA2 3127/4885CA4 4321/4885 |
| US-20060194849-A1 | Fungicidal composition and method for controlling plant diseases | CBR3, CNPY2, PAH | ACHE 1653/4885CA2 326/4885CA4 861/4885 |
| US-20230088747-A1 | COMPOUNDS FOR INHIBITING NEOVASCULARIZATION FACTORS AND USE THEREOF | FLT4, VEGFA, EDF1 | ACHE 3700/4885CA2 2903/4885CA4 1136/4885 |
| US-20070185064-A1 | 2-Aminopurine Analogs Having HSP90-Inhibiting Activity | HSP90AB2P, HSP90AB1, HSP90AA1 | ACHE 4876/4885CA2 4096/4885CA4 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.